Futura Medical plc (AIM:FUM)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.158
-0.073 (-5.89%)
Apr 15, 2026, 4:36 PM GMT
Market Cap6.73M -78.9%
Revenue (ttm)7.93M -5.6%
Net Income-6.29M
EPS-0.02
Shares Out581.33M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,433,956
Average Volume4,081,030
Open1.185
Previous Close1.230
Day's Range1.105 - 1.218
52-Week Range0.989 - 15.000
Beta0.19
RSI53.20
Earnings DateApr 17, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 14
Stock Exchange London Stock Exchange AIM
Ticker Symbol FUM
Full Company Profile

Financial Performance

Financial Statements

News

AIM Market Roundup: Quadrise, Iomart, Futura Medical

Quadrise, Iomart, Futura Medical are today's top risers, while Trellus Health, Engage XR take the biggest fall on London's AIM market

23 days ago - The Armchair Trader